Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Merck And Co., Inc patentsThe following is a sampling of recent Merck And Co., Inc patent applications (USPTO Patent Application #, Patent Title) sorted by month.
April 2008 - Merck And Co., Inc patents
20080095792 - Polypeptides for inducing a protective immune response against staphylococcus aureus
20080095850 - Process for granulating particles
20080096856 - Antibiotic compound
20080096859 - Compositions and methods for treating ophthalmic diseases
20080096878 - Bicyclic anilide spirolactam cgrp receptor antagonists
20080096885 - Quinoline derivatives as neurokinin receptor antagonists
20080096920 - Histone deacetylase inhibitors
20080096927 - Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
20080096935 - Heterocyclic indanone potentiators of metabotropic glutamate receptors
20080097108 - Ophthalmic compositions for treating ocular hypertension
20080090274 - Process for the synthesis of (s)-1-(3,5-bis (trifluoromethyl)-phenyl-ethan-1-ol
20080090778 - Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof
20080090794 - Potassium channel inhibitors
20080090796 - Piperidine and azetidine derivatives as glyt1 inhibitors
20080090799 - 2-pyridinecarboxamide derivative having gk-activating effect
20080090806 - Cgrp receptor antagonists
20080090865 - Antidiabetic bicyclic compounds
20080085540 - Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast
20080085885 - Inhibition of voluntary ethanol consumption with non-peptidyl melanocortin-4 receptor agonists
20080085926 - Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
20080086006 - Process for making substituted piperidines
20080081803 - Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity
20080081811 - Selective inhibitors against cdk4 and cdk6 having aminothiazole skeleton
March 2008 - Merck And Co., Inc patents
20080076773 - Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20080076783 - Cycloalkyl keto piperidine tachykinin receptor antagonists
20080076795 - 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
20080076805 - Acyclic hydrazides as cannabinoid receptor modulators
20080076810 - Benzoureas having anti-diabetic activity
20080070894 - Novel substituted imidazole derivative
20080070895 - Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase
20080070899 - Cgrp receptor antagonists
20080070928 - Novel 2-heteroaryl-substituted benzimidazole derivative
20080070940 - 4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same
20080063656 - Adenoviral vector compositions
20080064632 - Combination therapy for the treatment of obesity
20080057529 - Method for identifying histone deacetylase inhibitors
20080058347 - Novel aminopyridine derivatives having aurora a selective inhibitory action
20080058522 - Process for the preparation of enantiomerically enriched beta amino acid derivatives
February 2008 - Merck And Co., Inc patents
20080051403 - Treatment for alzheimer's disease and related conditions
20080051430 - Acylated piperidine derivatives as melanocortin 4-receptor agonists
20080045492 - Mitotic kinesin inhibitors
20080045515 - Cyclic sulfonamides for inhibition of gamma-secretase
20080045533 - Novel cyclohexyl sulphones
20080039494 - 8-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists
20080039514 - Compounds for the treatment of dyslipidemia and other lipid disorders
20080032951 - Ophthalmic compositions for treating ocular hypertension
20080032959 - Estrogen receptor modulators
20080032980 - Mitotic kinesin inhibitors
20080032996 - Substituted quinazoline or pyridopyrimidine derivative
20080033015 - Histone deacetylase inhibitors
20080033028 - Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
January 2008 - Merck And Co., Inc patents
20080027042 - Novel aminopyridine derivatives having aurora a selective inhibitory action
20080027058 - Mitotic kinesin inhibitors
20080027093 - Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20080027095 - Use of 3-substituted-2-(diphenylmethy)-1-azabicyclo[2.2.2]octanes for treating mrg-x1 receptor mediated diseases
20080027118 - Prodrugs of mitotic kinesin inhibitors
20080021001 - Methods for treating arthritic conditions in dogs
20080021009 - 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20080021010 - Azetidine glycine transporter inhibitors
20080021043 - Piperidines and related compounds for treatment of alzheimer's disease
20080021047 - C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase
20080021057 - 3,3-disubstituted tetrahydropyranyl cyclopentyl amide modulators of chemokine receptor activity
20080021061 - Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
20080021067 - Methods for the treatment of substance abuse and addiction
20080015173 - Estrogen receptor modulators
20080015187 - Hiv integrase inhibitors
20080015190 - Inhibitors of histone deacetylase
20080015212 - Inhibitors of akt activity
20080015213 - Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease
20080015216 - Histone deacetylase inhibitors
20080015233 - 2,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
20080008708 - Tyrosine kinase inhibitors
20080009016 - Novel monkey gpr103 and monkey qrfp and method of evaluating compound by using gpr103
20080009490 - Hiv integrase inhibitors
20080009507 - Inhibitors of akt activity
20080009510 - Fused aminopiperidine as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20080009518 - 5-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists
20080004259 - Inhibitors of checkpoint kinases
20080004304 - Aryl spirolactam cgrp receptor antagonists
December 2007 - Merck And Co., Inc patents
20070298099 - Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide
20070298498 - Adenoviral amplicon and producer cells for the production of replication-defective adenoviral vectors, methods of preparation and use thereof
20070299048 - Combination of gaboxadol and 5ht2 antagonists
20070299070 - 2-arylcarboxamide-nitrogenous heterocycle compound
20070299101 - Niacin receptor agonists, compositions containing such compounds and methods of treatment
20070299104 - Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity
20070299122 - Method of treating pathological blushing
20070292504 - Pharmaceutical formulation containing a release rate controlling composition
20070292895 - Assays and methods to detect beta-secretase and its activity in body fluids and tissue extracts
20070293470 - Carboxamide spirolactam cgrp receptor antagonists
20070293492 - Quinoline tachykinin receptor antagonists
20070293497 - 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
20070293515 - 1,3-disubstituted heteroaryl nmda/nr2b antagonists
20070293558 - Ophthalmic compositions for treating ocular hypertension
20070293578 - Cathepsin cysteine protease inhibitors
20070293706 - Synthesis of 1,5-disubstituted-2-hydroxy-gibbatetraen-6-ones
20070287696 - Cgrp receptor antagonists
20070287697 - Cgrp receptor antagonists
20070287716 - Pyrimidine and quinoline potentiators of metabotropic glutamate receptors
20070287736 - Diphenyl substituted alkanes as flap inhibitors
20070281941 - Amorphous form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
20070281952 - Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
20070281969 - Niacin receptor agonists, compositions containing such compounds and methods of treatment
November 2007 - Merck And Co., Inc patents
20070274916 - Method for identifying compounds that affect expression of tryptophan hydroxylase isoform 2
20070275379 - Simian orl1 gene and method of assessing compound
20070275912 - Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
20070269405 - Androgen receptor modulators
20070264278 - Polypeptides for inducing a protective immune response against staphylococcus aureus
20070264674 - Cytochrome p450 induction assay
20070265225 - Substituted monocyclic cgrp receptor antagonists
20070265222 - Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
20070265318 - Estrogen receptor modulators
20070265332 - Antidiabetic bicyclic compounds
20070265442 - Process for {3-[2(r)-[(1r)-1-[3,5-bis (trifluoromethyl) phenyl]ethoxy]-3(s)-(4-fluorophenyl) morpholin-4-yl}-5-oxo-4,5-dihydro-[1,2,4]-triazol-1-yl}phosphonic acid
20070259894 - Use of atazanavir for improving the pharmacokinetics of drugs metabolized by ugt1a1
20070259912 - Polymorphic forms of a gabaa agonist
20070259959 - Ppar agonists for the treatment of hcv infection
20070254865 - Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20070254879 - Inhibitors of checkpoint kinases
20070254880 - Heteroaryl piperidine glycine transporter inhibitors
20070254892 - Dihydropyrazolopyrimidinone derivatives
20070254901 - Inhibitors of akt activity
20070254958 - Phenyl carboxamide compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
October 2007 - Merck And Co., Inc patents
20070248613 - Human antibodies interacting with hiv gp41
20070249606 - Morpholinyl piperidine glycine transporter inhibitors
20070249659 - Imidazopyridine compound
20070243205 - Polypeptides for inducing a protective immune response against staphylococcus aureus
20070243266 - Fluorinated 4-azasteroids as androgen receptor modulators
20070244048 - Neuromedin u receptor agonists and uses thereof
20070244055 - Conjugates useful in the treatment of prostate cancer
20070244107 - Method of treating atherosclerosis, dyslipidemias and related conditions
20070244119 - 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
20070244297 - Human calcium channel compositions and methods
20070244329 - Enantioselective synthesis of 13-oxotricyclo[8.2.1.0. 3,8] trideca-3(8),4,6-triene-5-carboxylates
20070238723 - Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
20070231874 - Crystal of glucokinase protein, and method for drug design using the crystal
20070232676 - Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20070232678 - (4, 5, 6, 7-tetrahydro-1-h-indol-7-yl) acetic acid derivatives for treatment of alzheimer's disease
September 2007 - Merck And Co., Inc patents
20070224212 - Stable peptide mimetic of hiv gp41 fusion intermediate
20070224263 - Aminoalkylphosphonates and related compounds as edg receptor agonists
20070225229 - N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
20070225272 - Cgrp receptor antagonists
20070225365 - Cetp inhibitors
20070225499 - Process for the preparation of 2,2-disubstituted pyrroles
20070225520 - Stereoselective synthesis of a 4,4-disubstituted cyclohexanepropanoic acid
20070219252 - Vla-r antagonists
20070219354 - Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
20070219382 - Process for making n-sulfonated-amino acid derivatives
20070213329 - Sulphones which modulate the action of gammasecretase
20070213332 - Prodrugs of substituted amino heterobicycles which modulate the function of the vanilloid-1 receptor (vr1)
20070213338 - Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain
20070208010 - Fused triazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20070208017 - 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors
20070208046 - Pyridone derivative
August 2007 - Merck And Co., Inc patents
20070202547 - Methods for detecting substances which bind to the amyloid precursor protein or beta amyloid fragments, and binding compounds
20070203102 - Estrogen receptor modulators
20070203119 - Combination therapy for the treatment of schizophrenia
20070203147 - 2-aminothiazole compounds useful as aspartyl protease inhibitors
20070203186 - Pyrazole amide derivatives, compositions containing such compounds and methods of use
20070203205 - Diarylsulfones as 5-ht2a antagonists
20070197571 - Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer' s disease
20070197585 - Use of cysteinyl leukotriene 2 receptor antagonists
20070197796 - Process for producing indolopyrrolocarbazole derivative
20070189865 - Amino cyclopropane carboxamide derivatives as bradykinin antagonists
20070191389 - Biaryl derivatives
20070191419 - Cycloalkanopyridine derivative
20070191433 - Acylated piperidine derivatives as melanocortin 4-receptor agonists
20070191438 - Methods for the treatment of hypertension
20070184488 - Beta-secretase substrates and uses thereof
20070185313 - Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
20070178462 - Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha1h, encoded proteins and methods of use thereof
20070178551 - Methods for producing modified glycoproteins
20070179158 - 2,6-disubstituted piperiddines as modulators
20070179190 - Vla-4 antagonists
20070179196 - Hiv integrase inhibitors
July 2007 - Merck And Co., Inc patents
20070172498 - Polypeptides for inducing a protective immune response against staphyloococcus aureus
20070173434 - Antidiabetic oxazolidinediones and thiazolidinediones
20070173507 - Dairyl-substituted five-membered heterocycle derivative
20070173525 - Tyrosine kinase inhibitors
20070167447 - Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
20070167453 - Nitrogenous fused heteroaromatic ring derivative
20070167635 - Cathepsin cysteine protease inhibitors
20070161542 - Ptb1b photoprobes
20070161639 - Hiv integrase inhibitors
20070161689 - Indoles having anti-diabetic activity
20070161695 - Hydroisoindoline tachykinin receptor antagonists
20070155660 - Inhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists
20070155731 - Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
20070155744 - N-benzyl-3,4-dihyroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4- carboxamide compounds useful as hiv integrase inhibitors
June 2007 - Merck And Co., Inc patents
20070148188 - Anthrax vaccine
20070148765 - Preservative-containing virus formulations
20070149529 - Amino heterocyclic modulators of chemokine receptor activity
20070149536 - Inhibitors of akt activity
20070149547 - Bipyridyl amides as modulators of metabotropic glutamate receptor-5
20070149553 - Mitotic kinesin inhibitors
20070149568 - N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
20070149579 - Novel pharmaceutical compounds
20070149761 - Hcv rna dependent rna polymerase
20070141636 - Method for identifying androgen receptor modulators with full or mixed agonist activity
20070142388 - Inhibitors of akt activity
20070142453 - 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment of alzheimer's disease and related conditions
20070142634 - Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease
20070142635 - Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds
20070134157 - Biological assay
20070134263 - Polypeptides for inducing a protective immune response against staphyloococcus aureus
20070135357 - Anti-hypercholesterolemic compounds
20070135423 - E-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (vr1) for the treatment of pain
20070135454 - Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1)
20070135474 - Ccr-2 antagonist salt
20070135475 - Process for the preparation of ccr-2 antagonists
20070129309 - Conjugates useful in the treatment of prostate cancer
20070129356 - Mitotic kinesin inhibitors
20070129372 - P38 kinase inhibiting agents
20070129374 - Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1)
20070129418 - Ophthalmic compositions for treating ocular hypertension
20070129548 - Polymorphs of an androgen receptor modulator
May 2007 - Merck And Co., Inc patents
20070122849 - Rhesus monkey p2x7 purinergic receptor and uses thereof
20070123470 - Enhancement of growth hormone levels with a dipeptidyl peptidase iv inhibitor and a growth hormone secretagogue
20070123505 - Heterocycle-substituted 3-alkyl azetidine derivatives
20070123524 - N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
20070123587 - Prodrugs of diaryl-2-(5h)-furanone cyclooxygenase-2 inhibitors
20070117797 - Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
20070117824 - Spirocyclic compounds
20070117847 - N-(3-(4-substituted-1-piperiding1)-1-phenylpropyl) substituted sulfonamides as nk-3 receptor antagonists
20070111253 - Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof
20070111957 - Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof
20070111982 - Carboxamide spirohydantoin cgrp receptor antagonists
20070104685 - Synthetic gene encoding human carcinoembryonic antigen and uses thereof
20070105091 - Real time assay for rotavirus
20070105127 - Method for producing modified glycoproteins
20070105827 - Estrogen receptor modulators
20070105901 - Novel piperidine derivative
20070105902 - 4-phenyl piperdine sulfonyl glycine transporter inhibitors
20070105914 - Substituted sulfonamides
20070105930 - Cyclic guanidines, compositions containing such compounds and methods of use
20070098636 - Method of identifying responders to treatment with insulin sensitizers
20070099880 - Estrogen receptor modulators
20070099884 - Combination therapy for the treatment of diabetes
20070099893 - Cathepsin cysteine protease inhibitors
20070099926 - Combination therapy for treating chronic inflammatory diseases
20070099950 - Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain
20070099951 - 4-oxo-1-(3-substituted phenyl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same
20070101449 - Transgenic animal having an amyloid precursor protein with a modified beta secretase cleavage site
April 2007 - Merck And Co., Inc patents
20070092526 - Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use
20070092961 - Process to cultivate brevundimonas diminuta for filtration validation
20070093496 - Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors
20070093544 - Benzamidazoles, compositions containing such compounds and methods of use
20070087052 - Effervescent bisphosphonate formulation
20070087346 - Orthogonal gene switches
20070087384 - Cynomolgus monkey dickkope-4, nucleotides encoding same, and uses thereof
20070088028 - 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
20070088042 - Fluorinated 4-azasteroid derivatives as androgen receptor modulators
20070088047 - 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
20070088058 - Aralkyl amines as cannabinoid receptor modulators
20070088063 - Gamma-secretase inhibitors
20070088070 - Pyrazole derivatives, compositions containing such compounds and methods of use
20070088071 - Acyl indoles, compositions containing such compounds and methods of use
20070088165 - Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
20070082067 - Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5
20070082906 - Inhibitors of akt activity
20070083037 - Monkey npy y4 receptor and method of evaluating compound
20070083045 - Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
20070077257 - Enhanced first generation adenovirus vaccines expressing condon optimized hiv1-gag, pol, nef and modifications
20070077642 - Steroid receptor modulation of gene expression
20070078098 - Anti-hypercholesterolemic compounds
20070078154 - Quinoline potassium channel inhibitors
20070078156 - Derivatives of n-(1h-indazolyl)-and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for treatment of pain
March 2007 - Merck And Co., Inc patents
20070048320 - Method for indentifying modulators of ppil2 useful for treating alzheimer's disease
February 2007 - Merck And Co., Inc patents
20070042343 - Forward mutation assay based on 5-fluorouracil resistance
20070042975 - Novel indolopyrrolocarbazole derivative with antitumor activity
20070043001 - Inhibitors of akt activity
20070043015 - Phenyl pyrrolidine ether tachykinin receptor antagonists
20070043014 - 3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
20070043042 - Quinoline potassium channel inhibitors
20070036824 - Optimized expression of hpv 58 l1 in yeast
20070037214 - Generation and selection of protein library in silico
20070037217 - Structure-based selection and affinity maturation of antibody library
20070037219 - Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof
20070037771 - Process for preparing branched ribonucleosides from 1,2-anhydroribofuranose intermediates
20070037784 - Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
20070037829 - 4-cycloakylaminopyrazolo pyrimidine nmda/nr2b antagonists
20070032491 - Combination of a glycine/nmda antagonist and a tachykinin nk-1 receptor antagonist for use in the treatment of neurodegeneration
20070032517 - Substituted naphthyridinone derivatives
20070032553 - Use of gabaa receptor agonists for the treatment of hearing, vestibular and attention disorders, intention tremor and restless leg syndrome
20070026477 - Whole cell assay involving cathepsin s
20070027071 - Hcv ns3 protease inhibitors
20070027171 - Cycloalkanepyrrolopyridines as dp receptor antagonists
20070027177 - Isoquinolinone potassium channel inhibitors
20070027188 - Ophthalmic compositions for treating ocular hypertension
20070027321 - Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
January 2007 - Merck And Co., Inc patents
20070021350 - Conjugates useful in the treatment of prostate cancer
20070021430 - Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
20070021442 - Hiv reverse transcriptase inhibitors
20070021453 - Novel spirochromanone derivatives
20070021454 - Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
20070021477 - Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
20070015234 - Whole cell assay for inhibitors of cathepsin k
20070015792 - N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives
20070015923 - Process for making hydroisoindoline tachykinin receptor antagonists
20070009979 - Cyclic gmp dependent protein kinase as a chemotherapeutic target for antiprotozoal agents
20070009989 - Synthetic heparanase molecules and uses thereof
20070010442 - Inhibitor of vascular endothelial cell growth factor
20070010491 - Ophthalmic compositions for treating ocular hypertension
20070010655 - Stationary phases and a purification process using the stationary phases
20070011757 - Transgenic rodents as animal models for modulation of b1 bradykinin receptor protein
20070004669 - Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
20070004681 - Methods for treating arthritic conditions
20070004714 - Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
December 2006 - Merck And Co., Inc patents
20060293299 - Substituted 3-alkyl and 3-alkenyl azetidine derivatives
20060293303 - Antiprotozoal imidazopyridine compounds
20060293339 - Biaryl substituted 6-membered heterocycles as sodium channel blockers
20060293358 - Tyrosine kinase inhibitors
20060293364 - Niacin receptor agonists, compositions containing such compounds and methods of treatment
20060293373 - Gamma-secretase inhibitors
20060293380 - Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
20060286114 - Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
20060286624 - Method for identifying selective growth inhibitors
20060287302 - Mitotic kinesin inhibitors
20060287326 - 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
20060287340 - 2-aminoquinoline derivatives
20060287348 - 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
20060287349 - 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
20060287373 - Cathepsin cysteine protease inhibitors
20060287394 - Composition and method for treating macular disorders
20060287402 - Cathepsin inhibitors
20060287528 - Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
20060281073 - Broadening adenovirus tropism
20060281181 - Adaptor-directed helper systems
20060281727 - Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20060281737 - Cyclohexyl sulphones as gamma-secreatase inhibitors
20060281743 - Isoquinolinone potassium channel inhibitors
20060281761 - 4-azasteroid derivatives as androgen receptor modulators
20060281796 - Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
20060281803 - Pyrazole modulators of metabotropic glutamate receptors
20060275761 - Tryptophan hydroxylase assay
20060275835 - Methods for identifying cell surface receptor protein modulators
20060276450 - Isoquinoline potassium channel inhibitors
20060276504 - Ophthalmic compositions for treating ocular hypertension
20060276514 - Tyrosine kinase inhibitors
20060276655 - Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
November 2006 - Merck And Co., Inc patents
20060270650 - Combination therapy for the treatment of obesity
20060270673 - Inhibitors of akt activity
20060270679 - Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
20060270704 - Isoquinolinone potassium channel inhibitors
20060270721 - Ep4 receptor agonist, compositions and methods thereof
20060270722 - Combination of a dipeptidyl peptidase-iv inhibitor and a dual ppar agonist for the treatment of diabetes and obesity
20060270841 - Assays to monitor amyloid precursor protein processing
20060264389 - Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
20060264390 - Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
20060264416 - Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
20060264474 - Pyrazole derivatives as gamma-secretase inhibitors useful in the treatment of alzheimer's disease
20060257944 - System and method for automated selection of t-cell epitopes
20060258646 - 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
20060258661 - 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
20060258668 - Use of phosphatase inhibitors as adjunct therapy for psychiatric disorders
20060258695 - Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
20060258701 - Novel 2-pyridinecarboxamide derivatives
20060258726 - 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
20060258840 - Peroxisome proliferator-activated receptor
20060258860 - N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
20060252741 - 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
20060252937 - Process for making fluorinated 4-azasteroid derivatives
20060246048 - Gene responsible for stargardt-like dominant macular dystrophy
20060247229 - Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides
20060247319 - Preparation of 4-bromotetrahydrofluoreneones
October 2006 - Merck And Co., Inc patents
20060239969 - Rhesus her2/neu, nucleotides encoding same, and uses thereof
20060240040 - Optimized expression of hpv 45 l1 in yeast
20060241107 - Androgen receptor modulators and methods of use thereof
20060241133 - Electrically variable pneumatic structural element
20060241299 - Process for making spirolactone compounds
20060233843 - Treatment of psychosis with a muscarinic m1 receptor ectopic activator
20060234962 - Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
20060234984 - Mitotic kinesin inhibitors
20060235021 - Phenylpyridazine derivatives as ligands for gaba receptors
20060235069 - Benzamide modulators of metabotropic glutamate receptors
20060226666 - Autoclavable vacuum lifter
20060228335 - Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof
20060228410 - Flavored taste-masked pharmaceutical formulation made using a one-step coating process
20060228697 - Method to confer cell culture replication activity to different hepatitis c virus isolates
20060229264 - Crystalline 6-n-pyridylmethylaminoindolocarbazole compounds
20060229307 - Substituted-1-phthalazinamines as vr-1 antagonists
20060223123 - Rhesus monkey nur77
20060223844 - Mitotic kinesin inhibitors
20060223850 - 8-(3-biaryl)phenylquinoline phosphodiesterase-4 inhibitors
September 2006 - Merck And Co., Inc patents
20060211677 - Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
20060211682 - Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20060211687 - Potassium salt of an hiv integrase inhibitor
20060211712 - Bicyclic anilide spirohydantoin cgrp receptor antagonists
20060211722 - Amino cyclobutylamide modulators of chemokine receptor activity
20060211735 - 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor
20060205686 - Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
20060205750 - Novel benzimidazole derivatives
20060205761 - Ccr-2 antagonists for treatment of neuropathic pain
20060205765 - Inhibitors of akt activity
20060205783 - Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity
20060198788 - Method of evaluating compound efficacious in treating obesity by using slc25a10
20060199958 - Process and intermediates for the preparation of pyrrolidine carboxylic acids
August 2006 - Merck And Co., Inc patents
20060191317 - Method of evaluating safety of liquids for drum storage
20060193926 - Di-arylsubstituted pyrrole modulators of metabotropic glutamate receptor-5
20060194780 - Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
20060194783 - Cgrp receptor antagonists
20060194807 - Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5
20060194838 - Polymorphic form of montelukast sodium
20060194855 - Method of treating migraines and pharmaceutical compositions
20060194977 - Process for the preparation of chiral beta amino acid derivatives by asymmetric hydrogenation
20060188515 - Polypeptides for inducing a protective immune response against staphylococcus aureus
20060188570 - Compressed tablet formulation
20060189577 - Tyrosine kinase inhibitors
20060189593 - Aryl spirohydantoin cgrp receptor antagonists
20060189600 - Benodiazepine spirohydantoin cgrp receptor antagonists
20060189630 - Mitotic kinesin inhibitors
20060189666 - Novel gamma-secretase inhibitors
20060189682 - Water soluble prodrugs of cox-2 inhibitors
20060189764 - Synthesis of functional polymers for use in organic synthesis and combinatorial chemistry
20060189800 - Indolopyrrolocabazole derivative and antitumor agent
20060183731 - 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity
20060183744 - Method for treating depression and/or anxiety
20060183755 - Tyrosine kinase inhibitors
20060183764 - Combination of gh secret agogues and pde4 inhibitors for the treatment of alzheimers disease
20060183785 - Biaryl substituted pyrazoles as sodium channel blockers
20060183897 - Biaryl substituted triazoles as sodium channel blockers
20060183904 - Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
20060177462 - Polypeptides for inducing a protective immune response against staphylococcus aureus
20060177817 - Codon-optimized papilloma virus sequences
20060178358 - Antiprotozoal imidazopyridine compounds
20060178363 - Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity
20060178370 - Ketopiperazine derivatives as bradykinin antagonists
20060178375 - Heteroaryloxy nitrogenous saturated heterocyclic derivative
20060178398 - Therapeutic compounds for treating dyslipidemic conditions
20060172999 - Tetrahydropyran compounds as tachykinin antagonists
20060173013 - Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
20060173023 - 2-(bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation
20060173046 - Hydroxypyridine cgrp receptor antagonists
20060173054 - Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase
20060173062 - Use of selective cyclooxygenase-2 inhibitors for the treatment of endometriosis
July 2006 - Merck And Co., Inc patents
20060165664 - Method of inducing an enhanced immune response against hiv
20060166966 - 4-amino-azepan-3-one compounds as cathepsin k inhibitors useful in the treatment of osteoporosis
20060166972 - Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator
20060167036 - Tyrosine kinase inhibitors
20060167045 - Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin ii type i receptor antagonist
20060167081 - Ep4 receptor agonists
20060159622 - Pharmacodynamic assay for inhibitors of 11-beta-hydroxysteroid dehydrogenase activity in animal tissues
20060160140 - Human nuclear receptor protein nnr7-1
20060160834 - Combination therapy for the treatment of hypertension
20060160853 - 2-[(4-benzyl)-1-piperidinyl)methyl]benzimidazole-5-ol derivatives as nr2b receptor antagonists
20060161005 - 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as edg receptor agonists
20060161020 - N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
20060154897 - Ophthalmic compositions for treating ocular hypertension
20060154899 - Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma
20060154929 - Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds
20060154930 - Substituted amino heterocycles as vr-1 antagonists for treating pain
20060154932 - Pharmaceutical compositions and method of treating parkinson's disease
20060147923 - Nucleic acid sequences encoding novel point mutations on mglur2 and mglur3
20060147934 - High speed assay for glycosyl transferases
20060148718 - Conjugates useful in the treatment of prostate cancer
20060148721 - Combination therapy for the treatment of dyslipidemia
20060148739 - Method of evaluating compound efficacious in treating obesity
20060148750 - Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol
20060148779 - Monocyclic anilide spirohydantoin cgrp receptor antagonists
20060148790 - Benzodiazepine cgrp receptor antagonists
20060148805 - Opthalmic compositions for treating ocular hypertension
20060148809 - Pyridazine derivatives as ligands for gaba receptors
20060149032 - Recombinant hepatitis b surface antigen
20060149069 - Process for synthesising useful intermediates for the preparation of avss3 receptor antagonists
20060149092 - Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Merck And Co., Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Merck And Co., Inc with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
